Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. DATA SOURCES: The first two patients in the United States treated with the novel Sera...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care Explor
Autori principali: Olson, Stephen W., Oliver, James D., Collen, Jacob, Bunin, Jessica, Gleeson, Todd D., Foster, Brian E., Simmons, Mark P., Chen, Hua W., Ficke, Jennifer B., Brown, Tara E., Nau, Mark T., Cebula, Brennan R., Kielstein, Jan, Chung, Kevin K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396271/
https://ncbi.nlm.nih.gov/pubmed/32766569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000180
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi